Literature DB >> 35437312

Blood pressure management for secondary stroke prevention.

Kazuo Kitagawa1.   

Abstract

Hypertension is the most important vascular risk factor for stroke; therefore, optimal blood pressure (BP) management is essential for the prevention of recurrent stroke; lowering BP was shown to reduce the risk of recurrent stroke by 25-30%. A recent meta-analysis showed that intensive BP lowering to levels <130/80 mmHg significantly reduced the risk of recurrent stroke compared to standard management with BP levels <140/90 mmHg. The benefit of intensive BP management is evident with regard to a reduced risk of intracranial hemorrhage. Therefore, clinical practice guidelines have established a target BP of <130/80 mmHg. However, the target BP needs to be individualized. A stepped-care approach for cautious BP lowering (usually to levels <140/90 mmHg) is preferred for patients with severe diseases of the major cerebral vessels, who have a high risk of recurrent ischemic stroke. In contrast, more aggressive BP lowering (to levels <120/80 mmHg) tends to benefit patients at high risk of intracranial hemorrhage. The selection of BP management strategies should be guided by the risk of recurrent ischemic and hemorrhagic strokes.
© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Blood pressure lowering; Hemorrhagic stroke; Intensive blood pressure control; Ischemic stroke; Stroke

Mesh:

Substances:

Year:  2022        PMID: 35437312     DOI: 10.1038/s41440-022-00908-1

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  1 in total

Review 1.  Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack.

Authors:  Thomas P Zonneveld; Edo Richard; Mervyn DI Vergouwen; Paul J Nederkoorn; Rob de Haan; Yvo Bwem Roos; Nyika D Kruyt
Journal:  Cochrane Database Syst Rev       Date:  2018-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.